NL-4C resource
The Dutch Comprehensive Childhood Cancer Commons, or NL-4C, is part of a world-wide effort to collect genomics and clinical data and make it available for research.
The NL-4C is a collection of harmonized omic (whole-genome and transcriptome sequencing) and clinical data of consented children treated at the Princess Máxima Center. By collecting this information, clinicians and researchers can better understand the genetic abnormalities underlying the different tumor subtypes, obtain new insights into tumor biology and ultimately advance drug development to provide better treatment options.
Purpose for research
Upon consent for collecting, processing and storing of patients’ material (e.g. tissue, blood or bone marrow) at the Maxima’s biobank, whole-genome and RNA sequencing are performed for research. The Maxima’s Big Data Core has developed computational analyses for sequenced material to detect somatic variants, single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs) and structural variants (SVs) as well as RNA-seq expression and gene-fusion analyses of patients’ tumor samples. These analyses help finding the genomic rearrangements present in pediatric cancer, ultimately serving to identify therapeutic targets, driving drug development and improving risk classification.
What can users do?
The NL-4C portal offers three levels of access: open access for patients, families and everyone interested in exploring the general demographics of the Dutch pediatric cohort; authorized access for registered users from trusted organizations, providing analysis tools and more detailed data exploration; and controlled access for researchers to access detailed data and run their analysis pipelines after approval by the Maxima Biobank Data Access Committee.
Importantly, the Big Data Core carefully curates and updates NL-4C data following standard Biobank and Data Access procedures. By adhering to institutional legal agreements and privacy regulations, the Big Data Core ensures patient information is safely used in the cloud, and children’s rights are preserved. NL-4C data is made available with the goal of accelerating pediatric cancer research and supporting precision medicine programs aimed at providing targeted therapies for individual children.
NL-4C portal
NL-4C is a cloud-based portal for the visualization, exploration and building of virtual cohorts to understand the genetic and clinical landscape of Dutch pediatric cancer patients. The NL-4C currently hosts (click on the image for a larger view):
* Please refer to the NL-4C portal for the latest number of omics data available from patients.
Contact
NL-4C is initiated by the Kemmeren group and is a scientific research infrastructure project funded by the Dutch Research Council (NWO), 2023-2028.
Princess Máxima Center project members
Patrick Kemmeren
Jayne Hehir-Kwa
Hinri Kerstens
Bas Tops
Harm van Tinteren
Jet Zoon
Karina Borja Jimenez






